Researchers conduct a retrospective, population-based cohort study of adult patients with metastatic breast cancer who underwent genomic profiling at academic institutions.

Discover how ctDNA revolutionizes multiple myeloma monitoring, tracking disease progression, and improving personalized ...

Neuropsychological tests are integral in the detection of cognitive decline associated with a variety of diseases. Renowned for their sensitivity, these ...

Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in molecular diagnostics testing and precision medicine, today announced a collaboration with Gabbi, a ...

Marking Rare Disease Day, Strand Life Sciences, a subsidiary of Reliance Industries and a leading genomics research company, ...

Timing is everything – that’s a familiar quip we’ve all heard. And with colon cancer screening, timing is vital. While colorectal cancer leads to 52,000 deaths each year, it’s among the most treatable ...

The one-time leader of the DNA analysis market – valued at $6 billion in 2021 – is now worth less than $100 million, a 99 ...

Today is Rare Disease Day, an annual observance to raise awareness about uncommon and often misdiagnosed medical disorders.

Beckett Hotchkiss, an 11-year-old boy, is bringing attention to a genetic disorder known as Marfan Syndrome. He's taken his ...

DES MOINES, Iowa (KCRG) - A lawsuit claims the former head of the University of Iowa OB-GYN department secretly used his own ...

A study led by UMass Chan Medical School researchers has demonstrated that a gene therapy to correct a mutation that causes ...

Has Margaret’s ( Kelli Williams) son come home? That seems to be the case on Found, but we’re still waiting for that DNA test ...